Liu, M. et al. 2015. Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway. Clinics. 70, 4 (Apr. 2015), 250–256. DOI:https://doi.org/10.6061/clinics/2015(04)06.